European Journal of Clinical Pharmacology

, Volume 70, Issue 8, pp 991–1002

Content validation of a tool for assessing risks for drug-related problems to be used by practical nurses caring for home-dwelling clients aged ≥65 years: a Delphi survey

  • Maarit S. Dimitrow
  • Sanna I. Mykkänen
  • Saija N. S. Leikola
  • Sirkka-Liisa Kivelä
  • Alan Lyles
  • Marja S. A. Airaksinen
Pharmacoepidemiology and Prescription

Abstract

Purpose

Home care services are becoming a critically important part of health care delivery as populations are aging. Those using home care services are increasingly older, more frail than previously, and use multiple medications, making them vulnerable to drug-related problems (DRPs). Practical nurses (PN) visit home-dwelling aged clients frequently and, thus, are ideally situated to identify potential DRPs and, if needed, to communicate them to physicians for resolution. This study developed and validated the content of a tool to be used by PNs for assessing DRP risks for their home-dwelling clients aged ≥65 years.

Methods

The first draft of the tool was based on two systematic literature reviews and clinical experience of our research group. Content validity of the tool was determined by a three-round Delphi survey with a panel of 18 experts in geriatric care and pharmacotherapy. An agreement by ≥80 % of the panel on an item was required.

Results

The final tool consists of 18 items that assess risks for DRPs in home-dwelling aged clients. It is divided into four sections: (1) Basic Client Data, (2) Potential Risks for DRPs in Medication Use, (3) Characteristics of the Client’s Care and Adherence, and (4) Recommendations for Actions to Resolve DRPs.

Conclusions

The Delphi process resulted in a structured DRP Risk Assessment Tool that is focused on the highest priority DRPs that should be identified and resolved. The tool also assists the PNs to identify solutions to these problems, which is a unique feature compared to similarly purposed prior tools.

Keywords

Geriatric pharmacotherapy Adverse drug reactions Drug-related problems Risk management Patient safety Primary care 

Supplementary material

228_2014_1699_MOESM1_ESM.doc (100 kb)
ESM 1(DOC 99 kb)

References

  1. 1.
    Pharmaceutical Care Network Europe (PCNE) (2009) http://www.pcne.org/sig/drp/drug-related-problems.php Accessed 18 December 2013
  2. 2.
    ElDesoky ES (2007) Pharmacokinetic-pharmacodynamic crisis in the elderly. Am J Ther 14:488–498PubMedCrossRefGoogle Scholar
  3. 3.
    Klotz U (2009) Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev 41:67–76PubMedCrossRefGoogle Scholar
  4. 4.
    Leikola SN, Virolainen J, Tuomainen L, Tuominen RK (2003) Airaksinen MS (2012) Comprehensive medication reviews for elderly patients: findings and recommendations to physicians. J Am Pharm Assoc 52:630–633CrossRefGoogle Scholar
  5. 5.
    Sinnemäki J, Saastamoinen LK, Hannula S, Peura S, Airaksinen M (2013) Starting an automated dose dispensing service provided by community pharmacies in Finland. Int J Clin Pharm. doi:10.1007/s11096-013-9899-0 PubMedGoogle Scholar
  6. 6.
    Teperi J, Porter ME, Vuorenkoski L, Baron JF (2009) The Finnish health care system: a value-based perspective, Sitra Reports 82. http://www.isc.hbs.edu/pdf/Finnish_Health_Care_System_SITRA2009.pdf Accessed 2 October 2013
  7. 7.
    World Health Organisation (WHO) (2012): Home care across Europe 2012, current structure and future challenges. http://www.euro.who.int/__data/assets/pdf_file/0008/181799/e96757.pdf Assessed 13 October 2013
  8. 8.
    Hammar T, Perälä ML, Rissanen P (2009) Clients’ and workers’ perceptions on clients’ functional ability and need for help: home care in municipalities. Scand J Caring Sci 23:21–32PubMedCrossRefGoogle Scholar
  9. 9.
    National Institute for Health and Welfare (2012). Statistical yearbook on social welfare and health care 2012. http://urn.fi/URN:ISBN:978-952-245-784-4 Accessed 2 October 2013
  10. 10.
    Sørbye LW, Hamran T, Henriksen N, Nordberg A (2010) Home care patients in four Nordic capitals—predictors of nursing home admission during one-year followup. J Multidiscip Healthc 3:11–18PubMedCentralPubMedCrossRefGoogle Scholar
  11. 11.
    Dimitrow M, Airaksinen M, Kivelä S-L, Lyles A, Leikola SN (2011) Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc 59:1521–1530PubMedCrossRefGoogle Scholar
  12. 12.
    The American Geriatrics Society (2012) Beers Criteria Update Expert Panel (2012) American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60:616–631CrossRefGoogle Scholar
  13. 13.
    Koecheler JA, Abramowitz PW, Swim SE, Daniels CE (1989) Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 46:729–732PubMedGoogle Scholar
  14. 14.
    Barenholtz Levy H (2003) Self-administered medication-risk questionnaire in an elderly population. Ann Pharmacother 37:982–987PubMedCrossRefGoogle Scholar
  15. 15.
    Fuller D, Watson R (2005) Validating a self-medication risk assessment instrument. Clin Eff Nurs 9:78–83CrossRefGoogle Scholar
  16. 16.
    Johnson M, Griffiths R, Piper M, Langdon R (2005) Risk factors for an untoward medication event among elders in community-based nursing caseloads in Australia. Public Health Nurs 22:36–44PubMedCrossRefGoogle Scholar
  17. 17.
    Langford BJ, Jorgenson D, Kwan D, Papoushek C (2006) Implementation of a self-administered questionnaire to identify patients at risk for medication-related problems in a family health center. Pharmacotherapy 26:260–268PubMedCrossRefGoogle Scholar
  18. 18.
    Gordon K, Smith F, Dhillon S (2007) Effective chronic disease management: patients’ perspectives on medication-related problems. Patient Educ Couns 65:407–415PubMedCrossRefGoogle Scholar
  19. 19.
    Pit SW, Byles JE, Cockburn J (2008) Prevalence of self-reported risk factors for medication misadventure among older people in general practice. J Eval Clin Pract 14:203–208PubMedCrossRefGoogle Scholar
  20. 20.
    Gusdal AK, Beckman C, Wahlström R, Törnkvist L (2011) District nurses’ use for an assessment tool in their daily work with elderly patients’ medication management. Scand J Public Health 39:354–360PubMedCrossRefGoogle Scholar
  21. 21.
    Rovers J (2003) Hagel H (2012) Self-assessment tool for screening patients at risk for drug therapy problems. J Am Pharm Assoc 52:646–652CrossRefGoogle Scholar
  22. 22.
    Finnish National Board of Education (2011) Vocational Qualification In Social and Health Care, Practical Nurse 2010 , Regulation 17/011/2010 Publications 2011:21 http://www.oph.fi/download/140436_vocational_qualification_in_social_and_healthcare_2010.pdf Accessed 13 October 2013
  23. 23.
    Dalkey N, Helmer O (1962) An experimental application of the Delphi method to the use of experts. The RAND corporation, Santa Monica, California 1962, Available at: http://www.rand.org/content/dam/rand/pubs/research_memoranda/2009/RM727.1.pdf. Accessed 23 January 2014
  24. 24.
    Mother D, Liberati A, Tetzlaff J et al for the PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6;e1000097 http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000097 Accessed 23 March 2013
  25. 25.
    Campbell SM, Cantrill JA (2001) Consensus methods in prescribing research. J Clin Pharm Ther 26:5–14PubMedCrossRefGoogle Scholar
  26. 26.
    © Metodix, Futunet, Internetix (2010) eDelfoi.fi 3.0 http://www.edelphi.fi/en/. Accessed 26 February 2011
  27. 27.
    Leikola SN, Tuomainen L, Ovaskainen H, Peura S, Sevòn-Vilkman N, Tanskanen P, Airaksinen MS (2009) Continuing education course to attain collaborative comprehensive medication review competencies. Am J Pharm Educ 73:108PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Sinnemäki J, Sihvo S, Isojärvi J, Blom M, Airaksinen M, Mäntylä A (2013) Automated dose dispensing service for primary healthcare patients: a systematic review. Syst Rev. doi:10.1186/2046-4053-2-1 PubMedCentralPubMedGoogle Scholar
  29. 29.
    Lampela P, Hartikainen S, Sulkava R, Huupponen R (2007) Adverse drug effects in elderly people—a disparity between clinical examination and adverse effects self-reported by the patient. Eur J Clin Pharmacol 63:509–515PubMedCrossRefGoogle Scholar
  30. 30.
    Cantrill JA, Sibbald B, Buetow S (1998) Indicators of the appropriateness of long-term prescribing in general practice in the United Kingdom: consensus development, face and content validity, feasibility, and reliability. Qual Health Care 7:130–135PubMedCentralPubMedCrossRefGoogle Scholar
  31. 31.
    Morris CJ, Cantrill JA (2003) Preventing drug-related morbidity—the development of quality indicators. J Clin Pharm Ther 28:295–305PubMedCrossRefGoogle Scholar
  32. 32.
    Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straad J (2009) The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients. A modified Delphi study. Scand J Prim Health Care 27:153–159PubMedCentralPubMedCrossRefGoogle Scholar
  33. 33.
    Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of US consensus panel of experts. Arch Intern Med 163:2716–2724PubMedCrossRefGoogle Scholar
  34. 34.
    Laroche ML, Charmes JP, Merle L (2007) Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol 63:725–731PubMedCrossRefGoogle Scholar
  35. 35.
    Gallagher P, Ryan C, Byrne S, Kennedy J, O'Mahony D (2008) STOPP (Screening Tool of Older Person's Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharm Ther 46:72–83CrossRefGoogle Scholar
  36. 36.
    Budnitz DS, Lovegrove MC, Shehab N, Richards CL (2011) Emergency hospitalizations for adverse events in older Americans. N Engl J Med 365:2002–2012PubMedCrossRefGoogle Scholar
  37. 37.
    Akins RB, Tolson H, Cole BR (2005) Stability of response characteristics of a Delphi panel: application of bootstrap data expansion. BMC Med Res Methodol 1(5):37CrossRefGoogle Scholar
  38. 38.
    Beers MH (1997) Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 157:1531–1536PubMedCrossRefGoogle Scholar
  39. 39.
    Stefanacci RG, Cavallaro E, Beers MH, Fick DM (2009) Developing explicit positive beers criteria for preferred central nervous system medications in older adults. Consult Pharm 24:601–610PubMedCrossRefGoogle Scholar
  40. 40.
    Dimitrow M, Leikola S, Kivelä SL, Airaksinen M, Mykkänen S, Puustinen J (2013) Inappropriate medication use among the aged. Review of the criteria. Duodecim. 129:1159–1566 Review. Finnish, Abstract in EnglishGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2014

Authors and Affiliations

  • Maarit S. Dimitrow
    • 1
  • Sanna I. Mykkänen
    • 1
  • Saija N. S. Leikola
    • 1
  • Sirkka-Liisa Kivelä
    • 1
    • 2
    • 3
    • 4
  • Alan Lyles
    • 1
    • 5
  • Marja S. A. Airaksinen
    • 1
  1. 1.Clinical Pharmacy Group, Faculty of PharmacyUniversity of HelsinkiHelsinkiFinland
  2. 2.Department of Family Medicine, Institute of Clinical MedicineUniversity of TurkuTurkuFinland
  3. 3.Unit of Family MedicineTurku University HospitalTurkuFinland
  4. 4.Satakunta Hospital DistrictPoriFinland
  5. 5.School of Health and Human ServicesUniversity of BaltimoreBaltimoreUSA

Personalised recommendations